KaloBios makes two appointments to management team
This article was originally published in Scrip
Executive Summary
KaloBios Pharmaceuticals has appointed Dr Jonathan Leff chief medical officer and has elected Gary Lyons to its board of directors. Dr Leff was previously vice-president and chief medical officer of Halozyme Therapeutics, while Mr Lyons is the former president and chief executive officer of Neurocrine Biosciences.